Infographic

Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech

After a year in which deal value fell across the healthcare sector, pharma and biotech companies are poised for an active 2021.

Infographic

Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech
en
Read more

Getting Ready for the Recovery in Healthcare M&A

Companies willing to invest shrewdly in the downturn will emerge from it stronger.
Explore the full report

Global M&A Report 2023

Bain’s fifth annual Global M&A Report examines the ups and downs of 2022 and the bold moves companies across all sectors can take to win in 2023 despite macroeconomic turbulence.
Tags

Come abbiamo aiutato i nostri clienti

Divestiture adds value to parent, subsidiary

Leggi un caso di studio

Recharging the pharmaceutical sales model

Leggi un caso di studio

Pharma go-to-market strategy

Leggi un caso di studio

Vuoi continuare la conversazione?

Aiutiamo i leader globali e le loro aziende ad affrontare problemi e a cogliere le opportunità. Sosteniamo cambiamenti e otteniamo risultati duraturi.

Contatta Bain

Come posso aiutarti?

Guarda tutti gli uffici